Have you thought about

checking our FAQ ?

Who can benefit from the NFI services?

4 specific cases:
  • Foreign companies in all sectors looking to expand in Hauts-de-France
  • French companies with no site in Hauts-de-France
  • Hauts-de-France companies with a succession plan
  • Foreign-owned companies in Hauts-de-France with a development project
Our services are not intended for :
  • French or international self-employed entrepreneurs
  • French companies wishing to export
  • International companies seeking distribution networks only

Why as the help of Nord France Invest?

Nord France Invest provides you with completely tailored, free of charge and confidential support. We centralize all the information you need to analyze your project. We facilitate your process to find a site, partners or land. We organize site visits. We accelerate your networking with future regional partners. Find out more about the agency's services on this page.

What type of project can support you in?

The agency supports job-creating investment projects. The nature of projects varies according to 3 main categories:
  • Start-up projects
  • Expansion of existing sites in the region
  • takeovers of regional businesses by international companies.
Nord France Invest's services are not aimed at capital investments.
Check the FAQ

Do you have an expansion project?

Leave us your contact details and we’ll get back to you by e-mail.

This field is for validation purposes and should be left unchanged.
Top !
HomeBusiness SectorHealth Industry

The health sector

in Hauts-de-France

Our comprehensive health ecosystem makes us France’s No. 3 region for the industry, with players in every segment—pharmaceutical and biotechnology companies, laboratories, specialized companies, start-ups and more. Thanks to our outstanding research teams and healthcare infrastructure, this historic Hauts-de-France industry remains vibrant today, offering turnkey solutions that make it easy to locate your business here.
Nord France Invest

France's #3 region for healthcare

The Hauts-de-France Region is on France’s top three regions for healthcare, supported by a substantial investment of 205 million euros in research and development for the benefit of regional companies. The region currently has 4,000 researchers and 80 laboratories dedicated to the advancement of medical sciences.

This concentration of scientific resources reinforces Hauts-de-France’s position as a major healthcare center of innovation. These figures illustrate the region’s commitment to promoting research and development, making a significant contribution to the evolution of the healthcare sector in France.

Key figures about the health sector in Hauts-de-France

  • 32 K employees
  • 1,100 companies
  • €12,5 bn in revenue
  • with €3,5 bn revenue for exports


Our region’s health sector includes a broad range of complementary players, covering the entire industry:

Tate & Lyle

A leader in cutting-edge
health segments


The power of the region’s health sector also comes from our outstanding research teams and healthcare facilities.

  • 160 hospitals and clinics
  • 80+ R&D laboratories
  • 4,000 public and private researchers
  • €205M investment in R&D


Fields of research excellence

  • Cancer
  • Metabolic and cardiovascular diseases
  • Neuroscience
  • Inflammatory diseases
  • Immunity
  • Infectious diseases
  • Pharmacology
  • Digital health and medical imaging


The Lille Pasteur Institute is a private charitable foundation independent of the Paris Pasteur Institute. It was founded in 1894, when Lille needed an institute capable of producing anti-diphtheria serum in quantities large enough to fight a region-wide epidemic, and it was here that the tuberculosis vaccine (BCG) was invented.

From its beginnings, the Lille Pasteur Institute has worked to improve health and quality of life, and today it is a beacon for the world.


Key figures

  • 6 multidisciplinary research units
  • a testing center
  • a nutrition department
  • an international vaccine center

Fields of excellence

  • Cardiovascular and neurodegenerative diseases
  • Inflammatory, infectious and parasitic diseases
  • Metabolic diseases
  • Cancer

GSK has been in the region for 30 years
discover the timeline of their project












🎯 Stérilyo, serving the pharmaceutical industry, sets up in Saint-Amand-les-Eaux

💰 Stérilyo acquired by Britain’s GSK

👥 120 employees

💉 Company starts packaging vaccines

👥 300 employees

👥 500 employees

💰 €600m investment in new production plant

💉 Expands GSK site to 14 buildings on 17 hectares

👥 650 employees

💉 Launch of shingles vaccine

👥 800 employees

💉 Production of Covid-19 vaccine additive gets underway

👥 Over 100 jobs created as production ramps up

💉 Over 1 billion vaccines delivered to 125 countries in 10 years

⏰ Production lines operating 24/7

💉 Production of malaria vaccine gets underway

👥 970 employees

🏗️ New training centre opens

👥 1 000 employees

High-quality treatment facilities
in Hauts-de-France

Elite healthcare institutions are another source of momentum for our dynamic health sector. Hauts-de-France is home to over 300 hospitals and clinics, with 2 major university hospital centers, one in Lille—with more healthcare professionals than any other center in Europe—and another in Amiens.


Lille CHU has the highest number of healthcare professionals anywhere in Europe—which gives it extraordinary potential for collaboration.

This complex includes:

  • 8 hospitals
  • 16,000 healthcare professionals
  • 1.4m patients annually
  • 3,200 beds
  • 4 universities and medical schools
  • 7 schools of paramedicine
  • 50 research teams

Lille CHU is also home to the French pharmaceutical industry’s No. 3 clinical research center, with 4,100 patients involved in clinical trials conducted and/or coordinated in Lille.

Its 50 research teams focus on:

  • Cardiometabolic health
  • Inflammatory diseases
  • Neuroscience
  • Cancer
  • Inflammation, infections and immunity
  • Healthcare technology


Regional center for cancer treatment and research

Founded in 1955, the Oscar Lambret Center is part of France’s Unicancer network.

In addition to participating in France’s national public hospital service, the Center is dedicated to stepping up the pace of cancer innovation for every patient in Hauts-de-France, from providing treatment to generating research projects to training the oncologists of the future.

Oscar Lambret Center sets the standards for oncology in France, focusing exclusively on:

  • treatment
  • research
  • training

Fast facts

  • A team of nearly 1,000, including 600 doctors, healthcare providers and researchers
  • Over 24,000 patients seen annually, including 7,500 new patients
  • Nearly 200 clinical trials conducted every year
  • Over 5,000 hours of academic training annually, including university-level, post-graduate and occupational training programs
  • Treatment of many different cancers, with a special focus on breast and other gynecological cancers, ENT and lung cancers, digestive and urogenital cancers, and pediatric cancers.
  • Cutting-edge medical equipment, including a medical imaging center, a nuclear medicine unit, an internal radiation therapy department, an operating room with a surgical robot and a radiation oncology center with three TomoTherapy® units, two CyberKnife® machines and two Halcyon® systems



Amiens-Picardie CHU is a healthcare center of excellence with 4 missions:

  • treating patients
  • conducting research
  • teaching
  • managing medical demographics

Its resources include:

  • 6,400 employees
  • 16 training centers for the paramedical professions
  • SimUSanté®, a healthcare simulation center with a global reputation

Amiens-Picardie University Hospital Center is also internationally recognized for its expertise in otolaryngology, neurosurgery, and pediatric, digestive, orthopedic and trauma surgery, and for its sophisticated medical equipment, including CyberKnife® technology, an interventional imaging procedure room, two robotic stereotactic procedure rooms, four MRI units (including one for research), and automated lab technology.

In addition, Amiens-Picardie CHU plays a leading role in a variety of nationwide projects, including the Facing Faces Institute, which will soon be a disfigurement research center with unrivalled expertise in facial reconstruction surgery



SimUSanté® is dedicated to research and training, from introductory courses to lifelong continuing education. This 4,000-sq m complex includes:

  • 51 simulation spaces spanning three floors, including simulated hospital environment and neighborhood, complete with a doctor’s office, pharmacy and home.
  • 43 areas with audiovisual capture equipment linked to on-site or remote debriefing spaces
  • Nearly 150 mannequins and simulators, including 12 high-fidelity units, and 15 image-processing consoles
  • An online platform for learning and sharing ideas
  • A space for working with the center’s partners in the business community


Easily find
your talent

We’re a young, densely populated region of 6 million residents, with one-third of our population under 25. Hauts-de-France trains 9% of the students in France, and 10% of the country’s engineers.

Over 20,000 students are enrolled in healthcare training programs. Lille’s medical school is France’s largest medical research and training center for all disciplines combined, with 400 students graduating each year.


  • Lille School of Pharmacy
  • Lille School of Dentistry
  • Lille School of Medicine
  • School of Health Engineering and Management
  • Medical training and research unit at Université de Picardie Jules Verne
  • Institute of Health Engineering


Trouvez facilement vos talents

A showcase site for your business :
The eurasanté busines park

The Eurasanté business park is a major showcase for the health industry in Hauts-de-France. Located on the edge of Lille University Hospital Center (CHU), this 300-ha site powers the region’s health ecosystem and is entirely dedicated to businesses in the health sector.

Key figures

  • 170 health-sector businesses on site
  • 3,400 employees

Leading players located in the park include Bayer France (HQ), Genfit, LFB, Diagast, Lesaffre and EFS

And the park’s proximity to the research laboratories at Lille CHU helps spur the emergence of cutting-edge businesses in the health sector. Eurasanté offers a unique growth opportunity for many companies, thanks to services provided by the world-class technology platforms on the campus.

Want to do business here? All the options are on the table:

  • Create a satellite location for your company in this vibrant business hub
  • Incubate your idea in Eurasanté’s Bio Incubator
  • Rent offices or labs, mixed-use or commercial space
  • Buy land or built space